Paul Tudor Jones Dexcom Inc Put Options Transaction History

Tudor Investment Corp Et Al

  • $15.5 Billion
  • Q1 2024

Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$75.49 - $124.16 $868,134 - $1.43 Million
-11,500 Reduced 76.67%
3,500 $434,000
Q3 2023

Nov 15, 2023
BUY
$86.06 - $137.93 $438,906 - $703,443
5,100 Added 51.52%
15,000 $1.4 Million
Q2 2023

Aug 14, 2023
BUY
$112.47 - $130.98 $854,772 - $995,447
7,600 Added 330.43%
9,900 $1.27 Million
Q1 2023

May 15, 2023
SELL
$104.0 - $122.92 $509,600 - $602,308
-4,900 Reduced 68.06%
2,300 $268,000
Q4 2022

Feb 14, 2023
BUY
$84.98 - $122.67 $611,856 - $883,224
7,200 New
7,200 $814,000
Q2 2022

Aug 15, 2022
BUY
$67.99 - $132.89 $353,548 - $691,027
5,200 New
5,200 $388,000

Others Institutions Holding DXCM

# of Institutions
1,123
Shares Held
352M
Call Options Held
4.19M
Put Options Held
4.54M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $43.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email